Cytokinetics (CYTK) Leases (2020 - 2024)
Historic Leases for Cytokinetics (CYTK) over the last 5 years, with Q3 2024 value amounting to $76.3 million.
- Cytokinetics' Leases fell 448.52% to $76.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $76.3 million, marking a year-over-year decrease of 448.52%. This contributed to the annual value of $79.0 million for FY2023, which is 453.24% down from last year.
- Per Cytokinetics' latest filing, its Leases stood at $76.3 million for Q3 2024, which was down 448.52% from $77.2 million recorded in Q2 2024.
- Cytokinetics' 5-year Leases high stood at $83.0 million for Q2 2021, and its period low was $2.9 million during Q4 2020.
- Its 5-year average for Leases is $73.4 million, with a median of $78.0 million in 2021.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 240129.96% in 2021, then crashed by 1306.53% in 2022.
- Over the past 5 years, Cytokinetics' Leases (Quarter) stood at $2.9 million in 2020, then soared by 2401.3% to $73.1 million in 2021, then rose by 13.12% to $82.7 million in 2022, then fell by 4.53% to $79.0 million in 2023, then fell by 3.35% to $76.3 million in 2024.
- Its Leases was $76.3 million in Q3 2024, compared to $77.2 million in Q2 2024 and $78.2 million in Q1 2024.